BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

A Big Break for Merck & Co., Inc. (MRK)? What the Wags Say…


7/13/2012 7:41:12 AM

Last night, Merck issued some surprising news about an experimental drug being developed to treat osteoperosis. A Phase III trial was ended early after the study of more than 16,000 patients, which began in 2007, met its primary efficacy outcomes, although the Data Monitoring Committee noted that safety issues remain in certain selected areas and a previously planned blinded extension trial will be needed to sort these out. The complete results will not be known for awhile, but the news was greeted as a pleasant surprise by investors, who have been cautious about the Merck pipeline and drove its stock up more than 4 percent by midday today. The new drug, called odanacatib, could become a much-needed successor to Fosamax, another osteoperosis drug in the bisophosponate class that generated $3 billion in annual sales before its patent expired four years ago.

Read at Pharmalot

Pharmalot
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES